XB-PHENO-16547
Xtr WT + dyrk1a CRISPR, Willsey HR et al. (2020)
Experiment + Assay: |
Xtr WT + dyrk1a CRISPR +
NF46 (RNA-Seq)
|
Manipulations: |
Manipulation Type |
Reagent |
Target Gene |
Stage |
Treatment Area |
CRISPR
|
dyrk1a
|
dyrk1a
|
NF stage 2 (2-cell)
|
blastomere
|
|
Conditions: |
Assay Type |
Assay Stages |
Antibody |
RNA-Seq
|
NF stage 46
to NF stage 46
|
|
|
|
Expression Phenotypes (22):
|
increased amount
apoe
expression in brain
|
increased amount
aurkb
expression in brain
|
increased amount
ccnb1.2
expression in brain
|
increased amount
ccnb2
expression in brain
|
increased amount
cdca7
expression in brain
|
increased amount
cdk1
expression in brain
|
increased amount
cfd
expression in brain
|
increased amount
cks1b
expression in brain
|
increased amount
colec12
expression in brain
|
increased amount
dlc
expression in brain
|
decreased amount
fos
expression in brain
|
decreased amount
hoxc6
expression in brain
|
increased amount
ly6g6c
expression in brain
|
decreased amount
myl1
expression in brain
|
decreased amount
mylpf
expression in brain
|
decreased amount
npas4
expression in brain
|
decreased amount
ocm4.4
expression in brain
|
increased amount
pimreg
expression in brain
|
increased amount
rbp4
expression in brain
|
decreased amount
scn2b
expression in brain
|
decreased amount
tnni2
expression in brain
|
decreased amount
tnnt3
expression in brain
|
|